Chen, Yih-Ting published the artcileAcute kidney disease and acute kidney injury biomarkers in coronary care unit patients, Product Details of C12H15ClO3, the publication is BMC Nephrology (2020), 21(1), 207, database is CAplus and MEDLINE.
Background: Acute kidney disease (AKD) describes acute or subacute damage and/or loss of kidney function for a duration of between 7 and 90 days after exposure to an acute kidney injury (AKI) initiating event. This study investigated the predictive ability of AKI biomarkers in predicting AKD in coronary care unit (CCU) patients. Methods: A total of 269 (mean age: 64 years; 202 (75%) men and 67 (25%) women) patients admitted to the CCU of a tertiary care teaching hospital from Nov. 2009 to Sept. 2014 were enrolled. Information considered necessary to evaluate 31 demog., clin. and laboratory variables (including AKI biomarkers) was prospectively recorded on the first day of CCU admission for post hoc anal. as predictors of AKD. Blood and urinary samples of the enrolled patients were tested for neutrophil gelatinase-associated lipocalin (NGAL), cystatin C (CysC) and interleukin-18 (IL-18). Results: The overall hospital mortality rate was 4.8%. Of the 269 patients, 128 (47.6%) had AKD. Multivariate logistic regression anal. revealed that age, Hb, ejection fraction and serum IL-18 were independent predictors of AKD. Cumulative survival rates at 5 years of follow-up after hospital discharge differed significantly (p < 0.001) between subgroups of patients diagnosed with AKD (stage 0A, 0C, 1, 2 and 3). The overall 5-yr survival rate was 81.8% (220/269). Multivariate Cox proportional hazard anal. revealed that urine NGAL, body weight and Hb level were independent risk factors for 5-yr mortality. Conclusions: This investigation confirmed that AKI biomarkers can predict AKD in CCU patients. Age, Hb, ejection fraction and serum IL-18 were independently associated with developing AKD in the CCU patients, and urine NGAL, body weight and Hb level could predict 5-yr survival in these patients.
BMC Nephrology published new progress about 637-07-0. 637-07-0 belongs to chlorides-buliding-blocks, auxiliary class Inhibitor,Cell Cycle,PPAR, name is Ethyl 2-(4-chlorophenoxy)-2-methylpropanoate, and the molecular formula is C12H15ClO3, Product Details of C12H15ClO3.
Referemce:
https://en.wikipedia.org/wiki/Chloride,
Chlorides – an overview | ScienceDirect Topics